As I understand that with the recent patent battle regarding certain anti-carcinogenic drugs, the Swiss Multinational Novartis has opted to shrink its R&D investment in India. Do you feel that it will enhance your R&D activities especially in the fields of Vaccine Development & monoclonal antibodies? I am interested to know. However, in case it, in any way,create any possibility to affects your policy secrecy, please do not write anything.
HARI DATT PANDEY
Dear Sir / Madam,
I am not for a students of LPU. i am presently doing MLISc. from IGNOU new Delhi.
Kindly currect the my profile.
Nov 5, 2012
Siddhartha Shankar Ray
Dear Sri Pande:
As I understand that with the recent patent battle regarding certain anti-carcinogenic drugs, the Swiss Multinational Novartis has opted to shrink its R&D investment in India. Do you feel that it will enhance your R&D activities especially in the fields of Vaccine Development & monoclonal antibodies? I am interested to know. However, in case it, in any way,create any possibility to affects your policy secrecy, please do not write anything.
Best Wishes,
Siddhartha S. Ray, Calcutta
Apr 2, 2013
Mrs.Balvinder Kumari
BROCHURE.pdfNational Conference on
“Role of ICT in Library Management”
jointly organised by
Library Professionals Association (LPA), New Delhi &
Lyallpur Khalsa College of Engineering, Jalandhar (Punjab)
on
APRIL 26, 2014 (Saturday)
Venue: Lyallpur Khalsa College of Engineering, Cantt. Road, Jalandh...
Apr 20, 2014